Serum thyroglobulin measurements in differentiated thyroid cancer

被引:28
作者
Girelli, ME [1 ]
De Vido, D [1 ]
机构
[1] Ist Semeiot Med, Dipartimento Sci Med & Chirurg, I-35100 Padua, Italy
关键词
assay; differentiated thyroid cancer; serum thyroglobin; thyroid hormone suppression therapy;
D O I
10.1016/S0753-3322(00)80058-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In pathological states, the serum thyroglobulin (Tg) concentrations are generally high. Therefore, a serum assay of Tg levels is not useful for the differential diagnosis between benign or malignant disease in the preoperative period. Serum Tg measurements are a suitable marker in the follow-up of patients with differentiated thyroid carcinoma (DTC) during the postoperative period. After total thyroidectomy, serum Tg concentrations were found to be undectable in subjects without evidence of residual thyroid tissue or metastases; however, detectable serum Tg levels in subjects on and off thyroid hormone suppressive therapy indicate the presence of residual or metastatic thyroid tissue. An increase in serum Tg levels during thyroid stimulating hormone (TSH) suppression indicates that further investigations are necessary. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:330 / 333
页数:4
相关论文
共 20 条
[1]   THE COMPARATIVE VALUE OF SERUM THYROGLOBULIN MEASUREMENTS AND I-131 TOTAL-BODY SCANS IN THE FOLLOW-UP-STUDY OF PATIENTS WITH TREATED DIFFERENTIATED THYROID-CANCER [J].
ASHCRAFT, MW ;
VANHERLE, AJ .
AMERICAN JOURNAL OF MEDICINE, 1981, 71 (05) :806-814
[2]   LOW-LEVELS OF SERUM THYROGLOBULIN AFTER WITHDRAWAL OF THYROID SUPPRESSION THERAPY IN THE FOLLOW UP OF DIFFERENTIATED THYROID-CARCINOMA [J].
BRENDEL, AJ ;
LAMBERT, B ;
GUYOT, M ;
JEANDOT, R ;
DUBOURG, H ;
ROGER, P ;
WYNCHAUK, S ;
MANCIET, G ;
LEFORT, G .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 16 (01) :35-38
[3]   EUROPEAN INTERLABORATORY COMPARISON OF SERUM THYROGLOBULIN MEASUREMENT [J].
FELDTRASMUSSEN, U ;
SCHLUMBERGER, M .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1988, 11 (03) :175-181
[4]  
GIRELLI ME, 1985, EUR J NUCL MED, V10, P252
[5]   CRITICAL-EVALUATION OF SERUM THYROGLOBULIN (TG) LEVELS DURING THYROID-HORMONE SUPPRESSION THERAPY VERSUS TG LEVELS AFTER HORMONE WITHDRAWAL AND TOTAL-BODY SCAN - RESULTS IN 291 PATIENTS WITH THYROID-CANCER [J].
GIRELLI, ME ;
BUSNARDO, B ;
AMERIO, R ;
CASARA, D ;
BETTERLE, C ;
PICCOLO, M .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1986, 11 (09) :333-335
[6]   MEASUREMENT OF SERUM THYROGLOBULIN IS OF VALUE IN DETECTING TUMOR RECURRENCE FOLLOWING TREATMENT OF DIFFERENTIATED THYROID-CARCINOMA BY LOBECTOMY [J].
HARVEY, RD ;
MATHESON, NA ;
GRABOWSKI, PS ;
RODGER, AB .
BRITISH JOURNAL OF SURGERY, 1990, 77 (03) :324-326
[7]   SERUM THYROGLOBULIN IN THE FOLLOW-UP OF PATIENTS WITH TREATED DIFFERENTIATED THYROID-CANCER [J].
OZATA, M ;
SUZUKI, S ;
MIYAMOTO, T ;
LIU, RT ;
FIERRORENOY, F ;
DEGROOT, LJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) :98-105
[8]   Evaluation and treatment of persistent thyroglobulinemia in patients with well-differentiated thyroid cancer [J].
Pachucki, J ;
Burmeister, LA .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 137 (03) :254-261
[9]   DIAGNOSTIC-VALUE OF A SINGLE SERUM THYROGLOBULIN DETERMINATION ON AND OFF THYROID SUPPRESSIVE THERAPY IN THE FOLLOW-UP OF PATIENTS WITH DIFFERENTIATED THYROID-CANCER [J].
PACINI, F ;
LARI, R ;
MAZZEO, S ;
GRASSO, L ;
TADDEI, D ;
PINCHERA, A .
CLINICAL ENDOCRINOLOGY, 1985, 23 (04) :405-411
[10]  
PACINI F, 1987, J NUCL MED, V28, P1888